Header Logo

Connection

Kamyar Kalantar-Zadeh M.D. to Proteins

This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Proteins.
Connection Strength

1.152
  1. Protein carbamylation predicts mortality in ESRD. J Am Soc Nephrol. 2013 Apr; 24(5):853-61.
    View in: PubMed
    Score: 0.406
  2. Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren Nutr. 2003 Jan; 13(1):15-25.
    View in: PubMed
    Score: 0.201
  3. Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial. JAMA. 2020 04 28; 323(16):1565-1573.
    View in: PubMed
    Score: 0.167
  4. Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial. Am Heart J. 2019 11; 217:72-83.
    View in: PubMed
    Score: 0.159
  5. Apabetalone Mediated Epigenetic Modulation is Associated with Favorable Kidney Function and Alkaline Phosphatase Profile in Patients with Chronic Kidney Disease. Kidney Blood Press Res. 2018; 43(2):449-457.
    View in: PubMed
    Score: 0.144
  6. Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure. Semin Dial. 2004 Nov-Dec; 17(6):455-65.
    View in: PubMed
    Score: 0.057
  7. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008 Feb; 73(4):391-8.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.